Drugs / Canoderm
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06427889 | Sep 2024 → Nov 2025 overdue | diabetes mellitus | Malmö University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Canoderm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06427889 ↗ |
| Route | Topical | “Topical on feet twice a day” NCT06427889 ↗ |